• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风患者的髋部骨折。流行病学与康复

Hip fracture in stroke patients. Epidemiology and rehabilitation.

作者信息

Poplingher A R, Pillar T

出版信息

Acta Orthop Scand. 1985 Jun;56(3):226-7. doi: 10.3109/17453678508993000.

DOI:10.3109/17453678508993000
PMID:4036571
Abstract

With the purpose of identifying specific features in aged hemiplegic patients, 818 cases referred to a geriatric-rehabilitation hospital after hip fracture were studied. In 66 cases a cerebro-vascular accident had preceded the fracture, which was ipsilateral in 52 cases. No differences were found in incidence of concurrent disease, hospitalization time, mortality and functional recovery between hip fracture patients with and without a history of stroke, except that an interval of less than a week between stroke and fracture was associated with poor functional recovery. We conclude that rehabilitation of the stroke patient with hip fracture is worthwhile.

摘要

为了确定老年偏瘫患者的特定特征,对818例髋部骨折后转诊至老年康复医院的病例进行了研究。其中66例患者在骨折前发生过脑血管意外,52例为同侧脑血管意外。有或无中风病史的髋部骨折患者在并发疾病发生率、住院时间、死亡率和功能恢复方面均未发现差异,只是中风与骨折之间间隔少于一周与功能恢复不良有关。我们得出结论,髋部骨折的中风患者进行康复治疗是值得的。

相似文献

1
Hip fracture in stroke patients. Epidemiology and rehabilitation.中风患者的髋部骨折。流行病学与康复
Acta Orthop Scand. 1985 Jun;56(3):226-7. doi: 10.3109/17453678508993000.
2
Internal fixation versus conservative treatment for elderly patients with a trochanteric hip fracture in conjunction with post-stroke hemiplegia.老年股骨转子间骨折合并中风后偏瘫患者的内固定治疗与保守治疗对比
Injury. 2016 Oct;47(10):2169-2172. doi: 10.1016/j.injury.2016.07.011. Epub 2016 Jul 9.
3
Hip fracture after hemiplegia.偏瘫后髋部骨折。
Postgrad Med J. 1979;55(642):264-5. doi: 10.1136/pgmj.55.642.264.
4
Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation.中风4年多后,补充1α-羟基维生素D3和钙可改善偏瘫相关性骨质减少。
Stroke. 1997 Apr;28(4):736-9. doi: 10.1161/01.str.28.4.736.
5
A prospective study on hip fractures in patients with previous cerebrovascular accidents.一项关于既往有脑血管意外患者髋部骨折的前瞻性研究。
Injury. 1992;23(5):297-9. doi: 10.1016/0020-1383(92)90171-n.
6
Dual disabilities: when a stroke patient fractures a hip.
Orthop Nurs. 1996 Sep-Oct;15(5):13-20; quiz 21-2.
7
Outcomes and costs after hip fracture and stroke. A comparison of rehabilitation settings.髋部骨折和中风后的结局与成本。康复环境的比较。
JAMA. 1997 Feb 5;277(5):396-404.
8
Risedronate therapy for prevention of hip fracture after stroke in elderly women.利塞膦酸盐治疗预防老年女性中风后髋部骨折
Neurology. 2005 Mar 8;64(5):811-6. doi: 10.1212/01.WNL.0000152871.65027.76.
9
Post-stroke hip fractures.中风后髋部骨折
Arch Orthop Trauma Surg (1978). 1988;107(6):345-7. doi: 10.1007/BF00381059.
10
Gender differences influence the outcome of geriatric rehabilitation following hip fracture.性别差异影响髋部骨折后老年康复的结果。
Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):86-91. doi: 10.1016/j.archger.2009.02.004. Epub 2009 Mar 20.

引用本文的文献

1
Approach to patients with hip fracture and concurrent stroke.髋部骨折合并脑卒中患者的处理方法。
BMJ Case Rep. 2021 Feb 23;14(2):e236064. doi: 10.1136/bcr-2020-236064.
2
Change of Bone Mineral Density and Relationship to Clinical Parameters in Male Stroke Patients.男性中风患者骨密度的变化及其与临床参数的关系
Ann Rehabil Med. 2016 Dec;40(6):981-988. doi: 10.5535/arm.2016.40.6.981. Epub 2016 Dec 30.
3
Impact and risk factors of post-stroke bone fracture.中风后骨折的影响及危险因素
World J Exp Med. 2016 Feb 20;6(1):1-8. doi: 10.5493/wjem.v6.i1.1.
4
Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.中风后髋部骨折:患病率、临床特征、矿物质骨代谢、结局及预防方面的差距
Stroke Res Treat. 2013;2013:641943. doi: 10.1155/2013/641943. Epub 2013 Sep 25.
5
Management of patients with acute ischaemic stroke.
Drugs. 1997;54 Suppl 3:60-9; discussion 69-70. doi: 10.2165/00003495-199700543-00010.